What is Commonwealth Extracts?
Commonwealth Extracts, established in 2014, is a company focused on the extraction and testing of CBD products. Founded by John, who sought alternatives to manage seizures, the company emphasizes a strict non-toxic CO2 extraction methodology. Their in-house operations include rigorous testing overseen by a PhD chemist, ensuring product quality and providing Certificates of Analysis (COAs). The company's commitment to promoting its knowledge base and adhering to stringent extraction protocols positions it within the burgeoning wellness and alternative health sectors.
How much funding has Commonwealth Extracts raised?
Commonwealth Extracts has raised a total of $217K across 1 funding round:
Debt
$217K
Debt (2021): $217K with participation from PPP
What's next for Commonwealth Extracts?
The substantial capital infusion, particularly the recent strategic investment, signals a pivotal moment for Commonwealth Extracts. This backing is indicative of a company poised for significant scaling and market expansion. The focus will likely be on enhancing production capabilities, broadening distribution channels, and potentially exploring new product development or research initiatives. This late-stage funding suggests investor confidence in the company's established operational model and its potential for sustained growth within the competitive CBD market.
See full Commonwealth Extracts company page
